Enabling remote monitoring, more personalized diagnosis and treatments, better quality of care for HCPs – connectivity is inevitable in the medical devices and pharmaceuticals world. Echoed with this, the FDA has been open to supporting practitioners, yet also rapidly reviewing existing guidelines to ensure cybersecurity and compliance.
Building on the success of the inaugural event, this community will return to San Francisco in 2019 to discuss progresses, challenges and share solutions to overcome a number of problems:
Register your interest today and be the first to receive the brochure.
"Excellent conference with a diverse speaker panel that cover multiple aspects of combination products research and development!"
Previous Device Series Event Attendee - Pfizer
"The networking opportunity was fantastic. The meeting had a broad range of topics which interested a diverse panel of participants"
Previous Device Series Event Attendee - BD
“A very engaging, comprehensive and collaborative meeting!”
Previous Device Series Event Attendee - Merck